Fragility Fracture (Case 43)

Chapter 51
Fragility Fracture (Case 43)


Paul Sack MD


Case: The patient is a 67-year-old woman with a history of hypertension and osteoarthritis of the knees who presents to the emergency department after falling and fracturing her left hip. She lost her balance in her kitchen after turning and fell on her left hip. She had immediate pain and could not put any weight on her left leg. A radiograph revealed a femoral neck fracture of her left femur. She reports a wrist fracture 3 years ago after falling in her kitchen. This fracture was treated by an orthopedist in the outpatient setting. She has never had a dual-energy x-ray absorptiometry (DXA) scan performed. She occasionally takes a multivitamin, but does not take any additional calcium. She also takes atenolol for her hypertension. She is married and has two children. She went through menopause at the age of 44 years and was only briefly on hormone replacement therapy for 2 years. She has one or two alcoholic beverages on the weekends. She has never smoked tobacco.


Differential Diagnosis











Primary osteoporosis

Osteomalacia

Multiple myeloma


Secondary osteoporosis

Paget disease


 


Speaking Intelligently



The most common cause of a fragility fracture, a fracture that occurs with no or minimal trauma, is low bone density or osteoporosis. Unfortunately, osteoporosis does not cause symptoms until a fracture has occurred. Therefore, routine screening with a DXA scan is recommended for all patients at risk. The other main causes of a fragility fracture, such as multiple myeloma, Paget disease, and metastatic cancer, are usually fairly obvious with plain radiographs. Once the diagnosis of osteoporosis has been established, either on the basis of the DXA scan or by a clinical history of an osteoporotic fracture, the focus should be on prevention of the next fracture. This includes educating the patient about how to reduce the risk of a fall, ruling out secondary causes of bone loss, ensuring an adequate amount of calcium and vitamin D intake, and using prescription medications to help rebuild bone density and strength.


 


PATIENT CARE


Clinical Thinking


• Peak bone mass usually occurs in the third decade of life, and then bone mass diminishes with age.


• Estrogen deficiency accelerates this process, which is why women are more likely to have osteoporosis and osteoporotic fractures.


• Other conditions that can lead to accelerated bone loss or fragility fractures are hyperthyroidism, hyperparathyroidism, steroid excess (either exogenous or endogenous), vitamin D deficiency, and testosterone deficiency (in men).


• Other processes that can result in fragility fractures that are not necessarily due to osteoporosis include metastatic cancer, multiple myeloma, and Paget disease. Therefore, when a patient presents with a fragility fracture, it is important to rule out these other causes.


• Once the diagnosis of osteoporosis has been established and secondary causes have been either excluded or treated, the main goal of therapy is to decrease the risk of a future fracture.


History


• Osteoporosis is frequently a silent disease until a fracture occurs. As a result, many patients will not have any specific complaints. The history should therefore focus on identifying risk factors as well as potential secondary causes of osteoporosis.


• In a woman, estrogen deficiency is the main cause of osteoporosis. Late menarche, amenorrhea, and early menopause are important risks. If a woman is postmenopausal, determining the age of menopause and how much time (if any) the patient was on estrogen replacement therapy is important.


• In a man with osteoporosis, identifying causes, such as testosterone deficiency, are common. Therefore, specific questions regarding sexual drive (libido), erectile function, shaving habits, muscle strength, and overall energy are essential.


• Ascertain the patient’s intake of calcium and vitamin D; this includes intake of dairy products as well as OTC calcium and vitamins. Sunlight exposure should also be assessed, as lack of sunlight is a major risk factor for vitamin D deficiency. Vitamin D deficiency is also more common in patients with celiac disease, so it is important to note any symptoms of malabsorption.


• Certain medications may cause bone loss. The main offenders are glucocorticoids such as prednisone. Doses of prednisone over 10 mg/day for more than a few months will lead to worsening bone density. Phenytoin (Dilantin) diverts vitamin D to inactive forms, resulting in vitamin D deficiency and decreased calcium absorption. Androgen deprivation therapy medications used for treating prostate cancer will decrease testosterone production.


• Endocrinopathies that cause osteoporosis must be considered. To rule out hyperthyroidism, question patients about tremor, palpitations, heat intolerance, weight loss, and hair loss. Primary hyperparathyroidism is another silent disease, but the patient with hyperparathyroidism may have a history of kidney stones and hypercalcemia. Excessive weight gain, easy bruising, wide abdominal stretch marks, proximal muscle weakness with difficult-to-control diabetes or hypertension suggest Cushing syndrome (excess endogenous steroid production).


• Both smoking and excessive alcohol use, defined as more than three drinks a day, are risks for osteoporosis. A detailed family history for osteoporosis is important. While the family member may not have been officially diagnosed with osteoporosis, he or she may have had a hip fracture or severe kyphosis.


• The patient’s own history of fragility fractures is important. A hip fracture during a car accident is not considered an osteoporotic fracture, but a hip fracture after slipping on ice is. If there has been a vertebral compression fracture, patients will complain of localized, midline, sharp pains that may be disabling. Patients may also have height loss, scoliosis, or kyphosis as the vertebrae compress and change the contour of the spine. Pain is generally not associated with osteoporosis unless a fracture has already occurred.


Physical Examination


• The height measurement is essential when assessing the osteoporotic patient. An attempt should be made to determine if there has been height loss.


• Examine the spine for point tenderness, thoracic kyphosis, and an exaggerated cervical lordosis (dowager’s hump).


• The remainder of the physical exam should be focused on including or excluding the secondary causes of osteoporosis. Signs of hyperthyroidism include proptosis, an enlarged thyroid, tremor, tachycardia, warm and moist skin, and proximal muscle weakness. Cushing syndrome presents with central obesity, thin arms and legs, supraclavicular fat pads, a dorsocervical fat pad, widened purplish abdominal stretch marks, proximal muscle weakness, and hypertension.


Tests for Consideration































• 25-OH Vitamin D: This is the inactive or storage form of vitamin D. The vitamin D level should be at least above 32 ng/mL, and some experts are arguing for even higher levels. It is not recommended to check the active form (1,25-dihydroxyvitamin D3) in patients with normal kidney function. In patients with vitamin D deficiency as indicated by a low 25-OH vitamin D level, the active vitamin D can sometimes still be in the low normal range.

$55


• Intact PTH: In the setting of a normal or low calcium level, an elevated PTH level may indicate vitamin D deficiency.
This is known as secondary hyperparathyroidism. If the PTH is inappropriately elevated in the setting of an elevated calcium level, the diagnosis is primary hyperparathyroidism.

$59


• Calcium: The serum calcium concentration is tightly regulated in the body. PTH and vitamin D play an essential role in this regulation. Remember to correct the calcium if the albumin is not within the normal range.

$12


• Alkaline phosphatase: An elevated alkaline phosphatase can be found in both Paget disease and severe vitamin D deficiency (osteomalacia).

$12


• Testosterone (in men): Testosterone deficiency causes bone loss. A level less than 300 ng/dL should cause some suspicion for hypogonadism. A full evaluation of this should follow, including a free testosterone, FSH, LH, and prolactin.

$36


• TSH: A screening TSH level should be ordered in all patients with decreased bone density. Some patients with subclinical or mild hyperthyroidism may not have obvious symptoms, but the increased bone turnover associated with hyperthyroidism can lead to bone loss.

$24


• Cushing syndrome evaluation: This evaluation is not done routinely, but if the patient has the classic findings of Cushing syndrome or has unexplained early bone loss, it should be considered. This can be achieved with a 1-mg dexamethasone suppression test, a midnight salivary cortisol level, or a 24-hour urine for free cortisol.

$23, $23, $24


• Celiac disease evaluation: If you suspect malabsorption because of symptoms or if the patient continues to have low vitamin D levels despite aggressive replacement, celiac disease should be considered. IgA anti-tissue transglutaminase and IgA endomysial antibody levels are blood tests to evaluate for celiac disease.

$85


• Serum protein electrophoresis (SPEP) and/or urine protein electrophoresis (UPEP): If multiple myeloma is suspected, these tests will confirm or exclude the diagnosis.

$15, $25


 



IMAGING CONSIDERATIONS

























→ Plain films should be the first imaging tool for a fragility fracture. If osteoporosis is suspected, DXA should be the screening of choice. The other studies may be indicated depending on the diagnosis.

$45


→ DXA scan: The DXA scan is the most appropriate test to screen for osteoporosis. The mineral density of bone in the hips and spine (central skeleton) is assessed, and this density is expressed in grams per square centimeter. It is then compared to normal bone density (people with the same ethnicity and sex, but in their 20s, when bone density is at its peak). A standard deviation is calculated and expressed as a “T-score.” A T-score of zero indicates that the patient’s bone density is the same as the patient’s theoretical peak bone mass. A T-score greater than zero indicates a more dense bone, and a T-score less than zero indicates a less dense bone. A normal T-score is greater than –1.0. A T-score between –1.0 and –2.4 is considered osteopenia. A T-score of –2.5 or less is labeled osteoporosis. Another calculation is the Z-score, which compares the patient’s bone density to an age-matched reference group. While the T-score at the spine and hip are helpful in making the diagnosis of osteoporosis and estimating future fracture risk, it is important to understand that osteoporosis can also be diagnosed based on clinical information. If the patient has a fragility fracture and other causes have been ruled out, osteoporosis is the diagnosis regardless of the T-score on the DXA scan. It is still important to obtain the bone mineral density, so that it can be followed as the patient is treated.

$104


→ Peripheral bone density measurements: DXA, x-ray absorptiometry, and ultrasonography of the heel, wrist, or hand are less accurate than the DXA scan. However, the equipment is much cheaper and more portable than the DXA machine, so these techniques are commonly used at health fairs or for screening patients before they have a DXA scan. A low T-score on one of these tests can predict risk for fracture, but it is recommended not to make a diagnosis or decide on medications until a true DXA scan is performed on the hip and spine. A distal radius bone mineral density scan is sometimes useful in patients with hyperparathyroidism or hyperthyroidism, as this site is more sensitive to the rapid bone turnover associated with these conditions.

$46


→ Plain radiographs: The DXA scan is able to measure bone density, but plain radiographs are needed to look for compression fractures of the spine or other fractures. For example, if a patient presents with height loss and known osteoporosis, it is appropriate to order radiographs of the spine. A skeletal survey with plain films may show lytic lesions from multiple myeloma. Paget disease can also be easily identified on plain films.

$75


→ CT scan: If there is an area of concern on the radiograph, a CT scan may be useful in further defining the lesion.

$334


→ Nuclear bone scan: This study is indicated to find areas of active Paget disease or if metastatic cancer to the bone is suspected.

$247


→ MRI: This may be used if the suspected fracture is not seen on plain radiographs. In addition, it is used to assess the spine in patients with multiple myeloma.

$534

Related posts:

Hematuria (Case 16) Elevated Blood Counts (Case 26) Weight Loss (Case 41) Weight Gain and Obesity (Case 40) Amenorrhea (Case 42) Constipation (Case 23)

Stay updated, free articles. Join our Telegram channel
Tags:
Oct 3, 2016 | Posted by in MANUAL THERAPIST | Comments Off on Fragility Fracture (Case 43)

Full access? Get Clinical Tree
Get Clinical Tree app for offline access